HelixNano Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 9
  • Latest Deal Type
  • Series 1
  • Investors
  • 19

HelixNano General Information


Developer of mRNA therapeutics designed to treat Covid-19 variants, cancer and other diseases. The company uses artificial intelligence to leverage synthetic biology to safely and reliably express trans-genes in humans for next-generation gene therapies, genome engineering and beyond, thus allowing clinicians to treat patients suffering from CoVid-19.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 700 Main Street North
  • LabCentral
  • Cambridge, MA 02139
  • United States
+1 (415) 000-0000

HelixNano Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

HelixNano Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Seed Round 01-Jan-2021 00.000 Completed Pre-Clinical Trials
7. Seed Round 31-Mar-2020 00.00 00.000 Completed Pre-Clinical Trials
6. Seed Round 25-Jan-2018 00.00 00.000 Completed Pre-Clinical Trials
5. Accelerator/Incubator 22-Aug-2017 00000 00.000 Completed Startup
4. Seed Round 31-Dec-2016 00.00 00.00 Completed Startup
3. Accelerator/Incubator 01-Nov-2016 00000 Completed Startup
2. Accelerator/Incubator 09-Dec-2014 $100K Completed Startup
1. Accelerator/Incubator 01-Jan-2014 $100K $100K Completed Startup
To view HelixNano’s complete valuation and funding history, request access »

HelixNano Executive Team (5)

Name Title Board Seat Contact Info
Hannu Rajaniemi Ph.D Co-Founder & Chief Executive Officer
Nikolai Eroshenko Ph.D Co-Founder & Chief Scientific Officer
Carina Namih Co-Founder & Commercial Advisor
You’re viewing 3 of 5 executive team members. Get the full list »

HelixNano Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HelixNano Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
SVT Ventures Holding Company Minority 000 0000 000000 0
The Venture Collective Venture Capital Minority 000 0000 000000 0
Acequia Capital Venture Capital Minority 000 0000 000000 0
DCVC Venture Capital Minority 000 0000 000000 0
Esalen Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 19 investors. Get the full list »